Tanta University
Tanta, 35111, Egypt
Location status: Recruiting
Location contact
Sherief Abd-Elsalam
CONTACT
NCT Number: NCT03925701
Clinical study evaluating vildagliptin versus vildagliptin/metformin on NAFLD with DM.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 3
Tanta, 35111, Egypt
Location status: Recruiting
Sherief Abd-Elsalam
CONTACT
Clinical study evaluating vildagliptin versus vildagliptin/metformin on nonalcoholic fatty liver disease with DM.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
vildagliptin twice daily
Other names: dibavally
vildagliptin\\metformin twice daily
Other names: dibavally plus
Time frame: 6 months
number of patients showing improved nafld and insulin resistance
Contact information is provided by the study sponsor or research team.
Sherief Abd-Elsalam
Other
Clinical Study Evaluating the Effectiveness of Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07093476
DM, Diabete Type 2
Seoul, South Korea
View Trial DetailsNCT03925714
DM
Cairo, Egypt
View Trial DetailsNCT07160556
Acute Coronary Syndrome, Cardiovascular Diseases
Mardan, KPK, Pakistan
View Trial DetailsNCT00587301
Body Weight, DM
New York, United States
View Trial Details